In resistant HCC cells, enhanced autocrine generation of growth factors, such as interleukin (IL)-1, IL-4, IL-6, and IL-8, was observed in comparison to tumor cells responsive to treatment [129,130]. The gene discussed is IL6; the disease is neoplasm.